The Properties of Cytokines in Multiple Sclerosis: Pros and Cons
Authors:
- 1 December 2018
- journal article
- review article
- Published by Elsevier in The American Journal of the Medical Sciences
- Vol. 356 (6) , 552-560
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81471020, 81400770)
- Shandong University (2014QLKY21)
This publication has 110 references indexed in Scilit:
- Regulatory B cells control T-cell autoimmunity through IL-21-dependent cognate interactionsNature, 2012
- Discrepant Effects of Human Interferon-gamma on Clinical and Immunological Disease Parameters in a Novel Marmoset Model for Multiple SclerosisJournal of Neuroimmune Pharmacology, 2011
- Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosisNature, 2011
- The Immunopathophysiology of Multiple SclerosisNeurologic Clinics, 2011
- The encephalitogenicity of TH17 cells is dependent on IL-1- and IL-23-induced production of the cytokine GM-CSFNature Immunology, 2011
- Is multiple sclerosis a mitochondrial disease?Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2010
- Inflammatory cytokines in vascular dysfunction and vascular diseaseBiochemical Pharmacology, 2009
- Autoimmune T cell responses in the central nervous systemNature Reviews Immunology, 2009
- TNF‐mediated inflammatory diseaseThe Journal of Pathology, 2007
- Cytokines, Inflammation, and PainInternational Anesthesiology Clinics, 2007